mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.22 |
0.0003 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |